Chimerix Inc (CMRX) - NASDAQ
  • Agamemnus | Send Message 14 Mar

    Chimerix Conference Call Transcript For February 22, 2016 $CMRX http://seekingalpha.com/a/2cuaq
    Reply
      • John P. Rutledge | Send Message 8 Mar

        Why We've Left Our Truck Backed Up For Chimerix $CMRX http://seekingalpha.com/a/2ct2y
        Reply
          • thelach | Send Message 4 Mar

            Bought @ 4.98 - Sold @ 5.40 - will buy again if it goes back into $4.50 range $CMRX
            Reply
              • Agamemnus | Send Message 28 Feb

                CMRX: Efficacy Across A Broad Range Of Double-Stranded DNA Viruses. $CMRX http://seekingalpha.com/p/2vtv8
                Reply
                  • Agamemnus | Send Message 26 Feb
                    Reply
                      • Colin Macleod | Send Message 23 Feb

                        Clay Trader Chimerix Inc - $CMRX Stock Chart Technical Analysis for 02-22-16 http://bit.ly/21bAiL1
                        Reply
                          • WealthParadox | Send Message 22 Feb

                            Chimerix's Post-Hoc Analysis Of The SUPPRESS Trial Disappoints $CMRX http://seekingalpha.com/a/2bycw
                            Reply
                              • Alexander Valtsev | Send Message 22 Feb

                                10 Stocks Moving In Friday's Pre-Market Session: http://bit.ly/220216TRVIN $TRVN $RDUS $GOLD $LL $CMRX
                                Reply
                                  • wilkinson99 | Send Message 22 Feb

                                    $CMRX down 25% on 453K volume at $5.68
                                    Reply
                                      • Societe Financiers | Send Message 29 Jan

                                        $CMRX Chimerix Drama but still stable? http://tinyurl.com/gnp9p3g
                                        Reply
                                          Company Description
                                          Chimerix, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel, oral antiviral therapeutics designed to address unmet medical need. Its proprietary lipid technology to unlock the potential of some of the most broad-spectrum antivirals by... More
                                          Sector: Healthcare
                                          Industry: Drug Manufacturers - Other
                                          Country: United States